Live Breaking News & Updates on Stern Ir Inc|Page 5

Stay updated with breaking news from Stern ir inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Longeveron Receives Intent to Grant Notice from the European Patent Office for Methods to Monitor Efficacy of Lomecel-B™ Cell Therapy Through Levels of Vascular Biomarker

MIAMI, Aug. 25, 2022 Longeveron Inc. , a clinical stage biotechnology company developing cellular therapies for chronic, aging-related and life-threatening conditions, today announced that. | August 25, 2022 ....

United States , Elsie Yau , European Patent Office , Drug Administration , Company Quarterly Reports On Form , Longeveron Inc , Exchange Commission , European Patent Organization , Stern Ir Inc , Globenewswire Inc , Patent Office , Vascular Endothelial Growth Factor , Interim Chief Executive Officer , Chief Medical Officer , Monitoring Efficacy , Allogeneic Mesenchymal Stem Cell Therapy , Hypoplastic Left Heart Syndrome , Rare Pediatric Disease Designation , Orphan Drug Designation , States Food , Aging Frailty , Acute Respiratory Distress Syndrome , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Longeveron Inc Stock Exchange ,

Longeveron to Announce Second Quarter 2022 Financial

Live conference call on Friday, August 12 at 8:30 a.m. EST. ....

United States , Elsie Yau , Stern Ir Inc , Longeveron Or Company , Longeveron Inc , Dial In Number , Replay Dial In Number , Aging Frailty , Acute Respiratory Distress Syndrome , Nasdaq Lgvn ,

Decibel Therapeutics Reports Positive Data from Interim Analysis of Ongoing Phase 1b Clinical Trial of DB-020 in Patients Receiving Cisplatin Chemotherapy

- 87% of patients who experienced ototoxicity in their placebo-treated ear were protected from ototoxicity in their DB-020-treated ear – - Data support continued development of DB-020 as a. | June 28, 2022 ....

United States , Danny Rischin , Julie Seidel , John Lee , Laurence Reid , Ben Panizza , Chris Railey , Division Of Cancer Medicine , Exchange Commission , Stern Ir Inc , Neck Cancer Centre , Chief Development Officer , American Speech Language Hearing Association , Speech Intelligibility Index , Cancer Medicine , Medical Oncology , Peter Maccallum Cancer Centre , Queensland Head , Chief Executive Officer , Decibel Therapeutics , Private Securities Litigation Reform Act , Quarterly Report , Nc Stock Exchange , Press Release , S Dbtx Us24343r1068 ,

Werewolf Therapeutics Reports Fourth Quarter 2021 and Full Year 2021 Financial Results and Provides Business Highlights

24.03.2022 - -Closed upsized IPO in May 2021 raising $120 million in gross proceeds- -Announced clinical trial collaboration with Merck for WTX-124 INDUKINETM program- -Reported positive preclinical data at SITC demonstrating the potential to drive targeted . ....

United States , United Kingdom , Randi Isaacs , Ameeta Chatterjee , Chulani Karunatilake , Ellen Lubman , Danielj Hicklin , Jonathanm Nugent , Mike Sherman , Company Board Of Directors , Company Contact , Company Or Werewolf Nasdaq , Scientific Communications , American Society Of Hematology , Exchange Commission , Stern Ir Inc , Technology Officer , Werewolf Therapeutics Inc , Chief Executive Officer , Initial Public Offering , Annual Meeting , American Society , Two Industry Leaders , Operations Teams , Chief Technology , Manufacturing Controls ,

Decibel Therapeutics Reports on Continued Progress of Lead

- Podium presentation at Association for Research in Otolaryngology Annual MidWinter Meeting highlighting DB-OTO dose-ranging studies with expression. ....

United States , Julie Seidel , John Lee , Chris Railey , Regeneron Pharmaceuticals , Midwinter Meeting Of The Association For Research , Exchange Commission , Stern Ir Inc , Association For Research , Otolaryngology Annual Midwinter Meeting , Annual Midwinter Meeting , Chief Development Officer , Decibel Therapeutics , Private Securities Litigation Reform Act , Quarterly Report , Nasdaq Dbtx , Decibel Therapeutics , Hearing Loss , Gene Therapy , Balance Disorders , Hearing Science ,